Ensuring proper use, enhancing animal health and
protecting our technologies through a coordinated effort
Similar to the prescription requirement for injectable products, a veterinarian must issue a FDA-required Veterinary Feed Directive for Pulmotil® (tilmicosin).
- The VFD process requires a coordinated effort by the producer, veterinarian, feed supplier and feed advisor
- To start the process, contact your veterinarian to establish a protocol that meets the Pulmotil label requirements
- We encourage you and your veterinarian to contact your Elanco sales representative for more information about how to meet the requirements for fulfilling a VFD
VFD Central - your source for VFD news, insights and updates
Brought to you by Elanco and Feedstuffs, VFD Central helps producers, veterinarians and feed manufacturers find the most pertinent information in a one-stop online resource center. VFD Central is frequently updated with relevant information to help facilitate the industry's transition to a VFD approval process.
For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group: Feed continuously for a single, 14 day period at 568 grams to 757 grams per ton on a 100% dry matter basis of Type C medicated feed as the sole ration to provide 12.5 mg/kg of body weight/day.
Important safety information
The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions.
- CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment.
- To assure both food safety and responsible use, treatment must be initiated within the first 45 days of the production period. The treatment should not occur concurrent with or following administration of an injectable macrolide, or within 3 days following administration of a non-macrolide injectable BRD therapy.
- VFD expiration date must not exceed 45 days from the time of issuance. VFDs shall not be refilled.
- Use only in cattle fed in confinement for slaughter.
- Cattle with severe clinical illness should be evaluated for individual treatment with an alternative non-macrolide therapy.
- Do not use in female dairy cattle 20 months of age or older or in veal calves.
- Safety has not been established for cattle intended for breeding.
- Do not allow horses or other equines access to feeds containing tilmicosin.
- Avoid inhalation, oral exposure and direct contact with skin or eyes. Keep out of reach of children.